Abstract:Gangliosides are sialylated glycosphingolipids with essential but enigmatic functions in healthy and disease brains. GD3 is the predominant species in neural stem cells (NSCs) and GD3-synthase (sialyltransferase II; St8Sia1) knockout (GD3S-KO) revealed reduction of postnatal NSC pools with severe behavioral deficits including cognitive impairment, depression-like phenotypes, and olfactory dysfunction. Exogenous administration of GD3 significantly restored the NSC pools and enhanced the stemness of NSCs with multipotency and self-renewal, followed by restored neuronal functions. Our group discovered that GD3 is involved in the maintenance of NSC fate determination by interacting with epidermal growth factor receptors (EGFRs), by modulating expression of cyclin-dependent kinase (CDK) inhibitors p27 and p21, and by regulating mitochondrial dynamics via associating a mitochondrial fission protein, the dynamin-related protein-1 (Drp1). Furthermore, we discovered that nuclear GM1 promotes neuronal differentiation by an epigenetic regulatory mechanism. GM1 binds with acetylated histones on the promoter of N-acetylgalactosaminyltransferase (GalNAcT; GM2 synthase (GM2S); B4galnt1) as well as on the NeuroD1 in differentiated neurons. In addition, epigenetic activation of the GM2S gene was detected as accompanied by an apparent induction of neuronal differentiation in NSCs responding to an exogenous supplement of GM1. Interestingly, GM1 induced epigenetic activation of the tyrosine hydroxylase (TH) gene, with recruitment of Nurr1 and PITX3, dopaminergic neuron-associated transcription factors, to the TH promoter region. In this way, GM1 epigenetically regulates dopaminergic neuron specific gene expression, and it would modify Parkinson's disease. Multifunctional gangliosides significantly modulate lipid microdomains to regulate functions of important molecules on multiple sites: the plasma membrane, mitochondrial membrane, and nuclear membrane. Versatile gangliosides regulate functional neurons as well as sustain NSC functions via modulating protein and gene activities on ganglioside microdomains. Maintaining proper ganglioside microdomains benefits healthy neuronal development and millions of senior citizens with neurodegenerative diseases. Here, we introduce how to isolate GD3 and GM1 and how to administer them into the mouse brain to investigate their functions on NSC fate determination and nerve cell specification.

Preparation of Ganglioside GM1 by Supercritical CO2 Extraction and Immobilized Sialidase

Development of a Large Scale Process for the Conversion of Polysialogangliosides to Monosialotetrahexosylganglioside with a Novel Strain of Brevibacterium Casei Producing Sialidase.

Application of Immobilized Sialidase to Preparation of GM1 from Gangliosides

Enhancement of Bioconversion Gangliosides to Monosialotetrahexosylganglioside by in Situ Sialic Acid Removal and Recovery

Enzymatic Synthesis of Oligosaccharides and Conversion to Glycolipids

Efficient conversion from polysialogangliosides to monosialotetrahexosylganglioside using Oerskovia xanthineolytica YZ-2

Highly Efficient Conversion of Polysialoganglioside to Gm1 with Brevibacterium Casei As A Microbial Biocatalyst

Preparation of High-purity 1,3-Diacylglycerol Using Performance-enhanced Lipase Immobilized on Nanosized Magnetite Particles

Design, Synthesis and Neurite Outgrowth Activity of Novel Ganglioside GM1 Derivatives by Remodeling of the Fatty Acid Moiety

An Offline Two-Dimensional Supercritical Fluid Chromatography × Reversed Phase Liquid Chromatography Tandem Quadrupole Time-of-flight Mass Spectrometry System for Comprehensive Gangliosides Profiling in Swine Brain Extract.

Screening of Sialidase-Producing Microorganism and Optimization of Sialidase Production

Efficient Synthesis of a Sialic Acid α(2→3)Galactose Building Block and Its Application to the Synthesis of Ganglioside GM3

Efficient synthesis of a sialic acid alpha(2-->3)galactose building block and its application to the synthesis of ganglioside GM3.

Gangliosides in neural stem cell fate determination and nerve cell specification--preparation and administration

A modular chemoenzymatic cascade strategy for the structure-customized assembly of ganglioside analogs

Ganglioside GM1 and Central Nervous System Diseases

Synthesis of N-modified ganglioside GM3 derivatives

A facile method for controlling the reaction equilibrium of sphingolipid ceramide N-deacylase for lyso-glycosphingolipid production

Determination of disialoganglioside GD3 and monosialoganglioside GM3 in infant formulas and whey protein concentrates by ultra-performance liquid chromatography/electrospray ionization tandem mass spectrometry.

Synthesis of Per-acetyl Ganglioside GM3 Trisaccharide 4-Methoxyphenoside

Establishment of a targeted analysis method for gangliosides in mouse tissues by HILIC-ESI–MS/MS